| Target Price | HK$61.20 |
| Price | HK$53.00 |
| Potential |
15.47%
register free of charge
|
| Number of Estimates | 23 |
|
23 Analysts have issued a price target WuXi Biologics 2027 .
The average WuXi Biologics target price is HK$61.20.
This is
15.47%
register free of charge
HK$81.63
54.01%
register free of charge
HK$36.16
31.78%
register free of charge
|
|
| A rating was issued by 29 analysts: 23 Analysts recommend WuXi Biologics to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the WuXi Biologics stock has an average upside potential 2027 of
15.47%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 25.46 | 30.61 |
| 16.68% | 20.23% | |
| EBITDA Margin | 37.98% | 39.10% |
| 13.18% | 2.95% | |
| Net Margin | 22.53% | 24.11% |
| 25.35% | 7.03% |
26 Analysts have issued a sales forecast WuXi Biologics 2026 . The average WuXi Biologics sales estimate is
This results in the following potential growth metrics:
25 WuXi Biologics Analysts have issued a net profit forecast 2026. The average WuXi Biologics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | 1.37 | 1.78 |
| 47.31% | 29.93% | |
| P/E | 29.75 | |
| EV/Sales | 6.59 |
25 Analysts have issued a WuXi Biologics forecast for earnings per share. The average WuXi Biologics EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


